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Recently, we reported that cancer cells that recover from a potentially lethal damage gain new
phenotypic features comprised of mitochondrial structural remodeling associated with increased
glycolytic dependency and drug resistance. Here, we demonstrate that a subset of cancer cells,
upon recovery from a potentially lethal damage, undergo dedifferentiation and express genes,
which are characteristic of undifferentiated stem cells. While these cells are competent in
maintaining differentiated progeny of tumor, they also exhibit transdifferentiation potential.
Dedifferentiation is characterized by accumulation of hydrogen sulﬁde (H2S), which triggers up-
regulation of nicotinamide phosphoribosyltransferase (Nampt) accompanied by changes in the
redox state. The molecular events triggered by Nampt include elevated production of NADþ and
up-regulation of H2S producing enzymes, cystathionine beta synthase (CBS) and cystathionase
(CTH) with 3-mercaptopyruvate sulfurtransferase (MST) being detectable only in 3D spheroids.
Suppression of Nampt, or inactivation of H2S producing enzymes, all reduce H2S production and
reverse the ability of cells to dedifferentiate. Moreover, H2S induced stem cell markers in parental
cancer cells in a manner similar to that observed in damage recovered cells. These data suggest of
existence of a positive feedback loop between H2S and Nampt that controls dedifferentiation in
cancer cells that recover from a potentially lethal damage.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).lsevier Inc. This is an open access article under the CC BY-NC-ND license
/3.0/).
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In the past few years, the idea that cancers arise, progress, and
initiate new tumors from a small number of cells with the
capability of inﬁnite self-renewal and which harbor the potential
to differentiate has got a great momentum [1]. It is now
recognized that the molecular signature of such cells is similar
to that of embryonic stem cells (ESC). The expression of key
factors that control stem cell identity such as OCT4 has been
reported in a variety of cancers including hepatocellular, gastric
and cervical carcinomas [2–4]. It has been suggested that OCT4þ
cancer cells might be tumor-initiating stem cells, a concept that is
consistent with the role of this transcription factor in the
maintenance of stem cell pluripotency. However, the presence
of embryonic OCT4A in tumor tissue and tumor cell lines was
doubted by some who attributed the observed OCT4 expression to
the expression of OCT4 pseudogene [5–6]. On the other hand, the
expression of another important member of the pluripotency
regulatory network SOX2 (Sex-determining region Y (SRY)-Box2)
was also reported in various cancers and cancer cell lines [7–9]. It
has been suggested that SOX2 contributes to the dedifferentiation
of cancer cells, endowing them with highly aggressive properties
[7,10]. OCT4 and SOX2 cooperatively stimulate the transcription of
several downstream target genes such as NANOG, DPPA2 (devel-
opmental pluripotency-associated two), and FBXO15, which also
show oncogenic transformation activity [11–13].
The stem cell theory of cancer proposes two major concepts.
The ﬁrst concept suggests that cancers arise from malignant stem
cells that are present in somatic tissues, whereas the second
concept stresses the importance of dedifferentiation of somatic
cells due to factors in their microenvironment [14–16]. However,
the origin of cancer stem cells remains the subject of an intense
ongoing research; whether such cells give rise to tumors or are
generated within an existing tumor still remains an unanswered
question. Some view that tumors originate from mutant forms of
progenitor cells, adult stem cells or adult progenitor cells that
acquire stem cell properties. Others favor the idea that mutation
in the stem cells within their niche during development initiates
tumors [17]. According to a different conceptual framework, the
tumor is made up of several types of stem cells. Among these,
only one remains viable in the speciﬁc microenvironment that
harbors them while others, under the same conditions, are less
successful lines. These other lines, however, can become more
successful in adapting to other microenvironments or prevail in
response to treatment [18]. Another appealing idea is that
acquisition of stem cell like characteristics results from dediffer-
entiation of cancer cells. Such a notion is supported by a growing
number of reports showing that inﬂammation or damage can
cause dedifferentiation and generation of cells that exhibit a stem
like phenotype [19–20].
It is well known that tumor cells can recover from various types
of damage including X-radiation, oxidative stress, and hypoxia.
These early studies suggested that the pH and level of glucose are
the primary factors that play a crucial role in recovery of cancer
cells from Potentially Lethal Damage (PLD) [21–22]. Reduced
thiols and particularly glutathione are involved in cellular repair
mechanisms [23] and there is compelling evidence that hydrogen
sulﬁde (H2S) plays a prominent role in cell survival by regulating
intracellular redox homeostasis through cysteine-GSH connection[24]. H2S is a gasotransmitter and its intracellular production is
enzymatically regulated. There are three enzymes, which control
the production of H2S, namely, cystathionine β-synthase (CBS),
Cystathionase (CTH) also known as cystathione γ-lyase (CSE)
[25–26], and 3-mercaptopyruvate sulfurtransferase (MST)
[27–28]. H2S is produced in many different cell types and due
to its lipophilic nature, can easily diffuse without the need for
transporters [29]. In normoxic tissues, exogenous H2S is rapidly
metabolized, whereas in anoxic tissues, H2S is unaffected, pro-
tecting cells against hypoxia-induced injury [30–31].
Recently, we reported that cancer cells that recover from a
potentially lethal damage display mitochondrial reorganization
and increased drug resistance [32] similar to that which is found
in induced pluripotent stem cells (iPS). Here, we demonstrate that
upon recovery from a potentially lethal damage induced by
oxidative stress, hypoxia, or glucose deprivation, cancer cells
undergo dedifferentiation characterized by reactivation of expres-
sion of a repertoire of stem cell genes and plasticity to trans-
differentiate into another cell phenotype. This phenomenon is
dependent on the production of H2S and up-regulation of Nampt.
H2S acts as an inducer of Nampt, whereas Nampt, controls the
expression level of H2S generating enzymes and, thus, it ﬁne
tunes the level of intracellular H2S. We also show that cancer cells
that are exposed to exogenous H2S express stem cell markers in a
manner similar to that exhibited by cancer cells that recover from
a potentially lethal damage. These data show that cancer cells
modify their phenotype and gene expression pattern and de-
differentiate by a molecular switch comprised of H2S and Nampt.Materials and methods
Materials
Chemicals were purchased from Sigma-Aldrich Company (St Louis,
MO) or Fisher Scientiﬁc (Pittsburgh, PA). RNeasy Mini Kit for total
RNA isolation was purchased from Sigma-Aldrich. Nampt, SSEA1
and SSEA4 antibodies were from Abcam (Cambridge, MA), CBS and
CTH antibodies were from Santa Cruz Biotechnology (Santa Cruz,
CA), β-actin antibody was from Millipore (Billerica, MA) and
secondary antibodies were purchased from Jackson ImmunoRe-
search Laboratories (Baltimore, PA). H2S ﬂuorescent probe HSN2
was a kind gift from Professor Michael D. Pluth, University of
Oregon, Department of Chemistry, Eugene, Oregon. NAMPT-speciﬁc
siRNA was purchased from Santa Cruz Biotechnology.
Cell culture
CT26 mouse colon carcinoma cell line (CRL-2639), HepG2, MDA-
MB-231 and -435S cell lines were obtained from ATCC (Manassas,
VA). CT26 cells were cultured in RPMI 1640 with 2 mM glutamine,
10 mM HEPES, 1 mM sodium pyruvate, 25 mM glucose, 1.5 g/L
sodium bicarbonate, whereas HepG2, MDA-MB-231 and -435S
were maintained in DMEM with 2 mM glutamine and 25 mM
glucose, 0.1 mM non-essential amino acids and 10% fetal bovine
serum, in a 371C incubator with 5% CO2. Parental control (Pc) and
damage recovered (DR) cells were maintained in the same media
supplemented with 10% FBS. Pc cells were also maintained in α-
MEM medium supplemented with 5% FBS on either adherent or
ultra-low attachment suspension culture plates. Spheroid colonies
E X P E R I M E N T A L C E L L R E S E A R C H 3 3 0 ( 2 0 1 5 ) 1 3 5 – 1 5 0 137(Sp) were isolated from damage recovered cells and were main-
tained on ultra-low attachment suspension culture plates in α-
MEM media (Invitrogen, Carlsbad, CA) supplemented with 5% FBS,
4 μg/ml heparin, 20 ng/ml bFGF and 100 ng/ml EGF to facilitate
the Sp self-renewal. For expansion, spheroids were dissociated
with 0.05% trypsin/EDTA (Invitrogen) and passed every 5 days in
low-adherent suspension culture dishes (USA Scientiﬁc, Ocala, FL).
Only Sp and not parental cells maintained 3D structures and
expressed markers of stemness when grown on a low adhesion
suspension culture plates in the medium supplemented with 5%
FBS (Supplementary Fig. 1A–B). Spheroids could be dissociated by
trypsinization and re-plated weekly for three months without
evidence of loss of self-renewal ability or loss of viability
(Supplementary Fig. 1C).Animal experiments
Animal care and all procedures carried out following approval of
the Institutional Animal Care Committees of University of Cali-
fornia, Irvine (protocol number 2012-3042). The study included
10 eight-week-old, male athymic nude (Nu/Nu) mice, (Charles
River Laboratories, San Diego CA). Each athymic nude mouse
received 105 cells in a total volume of 100 μl subcutaneously in
four locations in the mid-abdominal and lower ﬂank areas. Half
hour before the tumor cell injection, animals were anesthetized
by inhalation of 1.5% isoﬂurane. Animals were monitored for
appearance, activity, pain and distress two to three times weekly.
Experimental time course varied depending on the type of tumor.
Mice were euthanized when the tumors grew to 1.5 cm in
diameter. At the end of the experiments, mice were euthanized
and tumors were removed, dissected out and viable and damaged
tumor cells were isolated.Table 1 – Sequence of RT-PCR and real time primers.
Gene description1 Product size (bp) Forward pr
β–ACTIN 221 AAGCCACCC
NANOG 237 TTGGGACTG
KLF4 396 ACGATCGTGG
OCT4 335 AGGTGTTCA
OCT4A 380 CTCCTGGAGG
OCT4B 302 ATGCATGAG
SSEA1 191 CTTCAACTGG
DPPA2 188 GGTGCCAGT
FBXO15 216 CCCACCAAAC
SOX2 150 GGGAAATGG
α–FETOPROTEN (AFP) 280 GAATGCTGC
E-CADHERIN 200 TGCCCAGAA
SNAIL 134 CATCTGAGT
CBS 286 GAACCAGAC
CTH 204 AAAGACGCC
MTS 239 CGCCGTGTCA
CYTOKERATIN 18 216 GGCATCCAG
ADIPONECTIN 248 TGCTGGGAG
NAMPT 172 ATCCTGTTCC
MYOGENIN 341 GGGGAAAAC
FIBRONECTIN 200 GAGAATAAG
1 Homo sapiens, PCR: polymerase chain reaction, bp: base pair, 1Numbers shWhole cell protein extraction and Western blotting
Proteins from cells were extracted in lysis buffer (50 mM Tris–HCl,
pH7.5, 150 mM NaCl, 1% NP-40, 2 mM EDTA, 1 mM PMSF, 1 mM
Na3VO4, 50 mM NaF, and protease inhibitor cocktail). Protein
measurements were carried out by Bio-Rad protein assay based
on Bradford dye-binding method (Bio-Rad Lab, Hercules, CA).
Blots were probed with antibodies as detailed in the results.
Bands were detected by ECL enhanced chemiluminescence (Ame-
rsham ECL Plus Western Blotting Detection Reagents, GE Health-
care Life Sciences, Pittsburgh, PA) using C-Digital Imager (Li-COR,
Lincoln, NE). Densitometric analysis was performed using
myImage Analysis software (Thermo Scientiﬁc, New Hampshire).
β-actin served as a loading control.Reverse transcription-polymerase chain reaction (PCR) and
quantitative PCR (qPCR)
Total RNA was isolated using GenElute™ Mammalian Total RNA
Miniprep Kit (Sigma-Aldrich). Reverse transcription was per-
formed using High-Capacity cDNA Reverse Transcription Kit
(Invitrogen).
Gene expression was assessed by PCR using Taq 5X Master Mix
(New England Biolabs. Ipswich, MA) with an initial denaturation
step at 941C for 5 min, followed by 30 cycles with each at 941C for
30 sec 551C for 30 sec, and 681C for 1 min. Quantitative evaluation
was performed by using myImage Analysis software (Thermo
Scientiﬁc). For normalization of data, gene expression was
assessed by qPCR using SYBR Green PCR Kit (Biorad). The plate
was read at every cycle at the predetermined temperature based
on the product melting curve. Sequences of the used primers for
the analyzed genes are shown in Table 1.imer Reverse primer
CACTTCTCTCT GAGACCAAAAGCCTTCATACATCT
GTGGAAGAATC GATTTGTGGGCCTGAAGAAA
CCCCGGAAAAGGACC TGATTGTAGTGCTTTCTGGCTGGGCTCC
GCCAAACGACC TGATCGTTTGCCCTTCTGGC
GCCAGGAATC CCACATCGGCCTGTGTATAT
TCAGTGAACAG CCACATCGGCCTGTGTATAT
ACGCTCTCCTA GTTGGTGGTAGTAGCGGACC
TAAAGATGACGC GAGGCAAAATGGTCGGCAAG
ATAGACTCCGA CGAGCCTAATGTGCTCCTCT
GAGGGGTGCAAAAGAGG TTGCGTGAGTGTGGATGGGATTGGTG
AAACTGACCACGCTGGAAC TGGCATTCAAGAGGGTTTTCAGTCTGGA
AATGAAAAAGG GTGTATGTGGCAATGCGTTC
GGGTCTGGAGG CTTCTCTAGGCCCTGGCTG
GGAGCAGACAA GTCGCTCAGGAACTTGGTCA
TCCTCACAAGG AAGGCAATTCCTAGTGGGATTTC
CTGCTTGAT CAGGTTCAATGCCGTCTCG
AACGAGAAGGAG ATTGTCCACAGTATTTGCGAAGA
CTGTTCTACTG TACTCCGGTTTCACCGATGTC
AGGCTATTCTGT CCCCATATTTTCTCACACGCAT
TACCTGCCTGTC AGGCGCTCGATGTACTGGAT
CTGTACCATCGCAA CGACCACATAGGAAGTCCCAG
ow start sites of the primers.
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Pools of three to ﬁve 19–25 nt NAMPT-speciﬁc siRNAs were
designed to knockdown NAMPT gene expression. For successful
gene transfection, spheroid colonies were dissociated by trypsi-
nization into a single cell suspension (2105 cells). Cells were
incubated in 6 cm dishes in 5% serum MEM medium supplemen-
ted with Lipofectamin containing 50 pmol of either NAMPT-
speciﬁc siRNA or control siRNA with a scrambled sequence. Cells
were transfected for 3 days. To determine the efﬁcacy of transfec-
tion, the expression of NAMPT was analyzed by RT-PCR and qPCR.
Histochemical staining
Fluorescence imaging of H2S in live cells was obtained with H2S
ﬂuorescent probe HSN2 (a kind gift of Professor Michael D. Pluth,
University of Oregon, Department of Chemistry, Eugene, Oregon)
by incubating cells in 5 μM HSN2 for 30 min.
For alkaline phosphatase staining, cells were ﬁxed and stained
with NBT/BCIP solution in NTMT (100 mM Tris pH 9.5, 100 mM
NaCl, 0,1% Tween-20) for 2 h at room temperature. Color reaction
was stopped by washing cells in phosphate buffered solution, and
samples were examined microscopically. Positive staining was
indicated by distinct brown staining.
For SSEA1 and SSEA4 immunostaining, cell cultures were ﬁxed
for 5 min in 2% buffered paraformaldehyde containing 0.02% NP40.
Cells were subjected to blocking for 10 min in 2% serum. Cells were
then incubated with the primary antibodies (1–2 μg/ml) followed
by the secondary antibody (1–2 μg/ml). The staining was developed
in 3,3'-diaminobenzidine (DAB)–H2O2 and viewed at the light
microscopic level without counterstain.Cell viability measurement
Relative cell number was measured by XTT assay (Sigma-Aldrich).
Cells were incubated with XTT and phenazine methosulfate (PMS)
at 37 1C for 2 h and absorbance was read at 450 nm and 650 nm
as reference.
Quantitation of Nampt, NADþ/NADH and thiols
Intracellular Nampt levels were measured using a Visfatin C-
terminal (Human) EIA kit (Phoenix pharmaceuticals, Belmont,
CA, USA).
NADþ/NADH levels were measured using NADþ/NADH assay kit
(Cayman Chemical Company, Ann Arbor, MO and BioAssay
Systems, Hayward CA) according to manufacturer's instruction.
Total thiols were quantitated by reaction of cells with 5,5'-
Dithio-bis(2-nitrobenzoic acid) (DTNB) and measurement of
absorbance at 412 nm. Thiols content was estimated from a
cysteine standard curve obtained in parallel for each assay.
Levels of NADþ, NADH and thiols were normalized to the
protein content.
Measurement of H2S production
Measurement of extracellular H2S level was performed using Free
Radical Analyzer (TBR4100 and ISO-H2S-2, World Precision
Instruments, Sarasota, FL) in accord with the manufacturers'instruction. Brieﬂy, sample cells were adjusted to 1  106 viable
cells per test with PBS, and the cell suspensions were incubated in
37oC incubator for 1 h. Cells were then centrifuged and the
supernatants were subjected to measurements. Prior to the
measurement, the sensor was polarized and calibrated by adding
four aliquots of the Na2S stock solution at the ﬁnal concentrations
of 0.25, 0.5, 1.0 and 2.0 μM.
Statistics
All assays were done in 3–6 replicates in at least three indepen-
dent experiments. Data are shown as mean7SEM. P values were
determined by comparing the data from experimental versus
control cells from at least three independent experiments or six
replicates of the same experiment. Means and p Values for
experimental data were analyzed by subjecting the data to the
two tailed t-test. p values less than 0.05 were considered
signiﬁcant. P values are shown as o0.05 (n), o0.005 (nn) or
o0.0005 (nnn).Results
Spheroids are formed by cancer cells that recover from a
potentially lethal damage
We chose hydrogen peroxide to induce injury in cancer cells since
it is produced in relatively large amounts by some tumor cells
reaching rates up to 0.5 nmol/104 cells/h [33]. Exposure of HepG2
cells to hydrogen peroxide resulted in cell death with LD50 being
800 μM. The pretreatment of cells with NaHS, a donor of H2S, for
18 h signiﬁcantly attenuated the effect of hydrogen peroxide
(Fig. 1A). Similar effect of NaHS was observed in MDA-MB-231
cells exposed to H2O2 for 3 h (Supplementary Fig. 2A). Consistent
with previous reports, protective effect of NaHS was due to
modulation of thiol homeostasis leading to increased total level
of reduced thiols (Fig. 1B). Within 24 h after treatment with H2O2,
few viable (trypan blue negative) cells remained attached to the
culture ﬂask while majority of cells detached due to mitosis or
severe damage ( Supplementary Fig. 2B–C). To isolate potentially
lethal damage-recovered (DR) cells, we ﬁrst removed the mitotic
and all viable cells by culturing cells in new culture vessels for
24 h. Then, ﬂoating cells that failed to bind to culture vessels but
had the potential to recover from damage were transferred to
new culture vessels. Serial weekly passages of ﬂoating cells to
new culture vessels for duration of 2 weeks allowed isolation of
damage-recovered (DR) cells. In cells which recovered from
damage induced by hydrogen peroxide (DRH2O2) and began to
proliferate, the γ-H2AX level was low (Fig. 1C). The dephosphor-
ylation of H2AX in DR cells signaled the completion of repair [34].
The level of reduced thiols increased in DR cells compared with
parental control cells (Pc) (Fig. 1D, Supplementary Fig. 2D) ind-
icating that endogenous H2S might play a cytoprotective role in
potentially lethal damage recovery (PLDR). Indeed, increase in the
level of thiols was associated with increase in H2S in cells that
recovered from damage (Fig. 1E–F). We have employed two
techniques to study intracellular production of H2S. The H2S
release was measured by using sulﬁde-sensitive electrode and
intracellular H2S synthesis was visualized by the ﬂuorescent
probe, Hydrosulﬁde Naphthalimide-2 (HSN2), a kind gift of
Fig. 1 – Endogenous hydrogen sulﬁde level increases in cancer cells after recovery from a potentially lethal damage. A. Cell viability
was measured by XTT assay in HepG2 cells pre-treated for 24 h with 100 μM of NaHS and then subjected to H2O2 (800 μM) for 3 h. B.
Total level of thiols in Pc HepG2 cells treated for 24 h with 0, 10, and 100 μM of NaHS. The levels of thiol were normalized to the
level of total protein. C. The level of γH2AX assessed by western blot analysis in HepG2 Pc and DRH2O2 cells. D. Total thiol levels in
HepG2 Pc, DRH2O2 and SpH2O2 cells. The levels of thiol were normalized to the level of total protein. E. Amount of H2S released by
HepG2 Pc, DRH2O2 and SpH2O2 cells. F. H2S staining of HepG2 Pc, DRH2O2 and SpH2O2 cells stained with 5 μM H2S ﬂuorescent probe,
HSN2. Scale bars, 100 μM. G. Representative images of emerging spheroid-forming cells in HepG2 cells recovered from damage
induced by hypoxia (SpH), glucose deprivation (SpG-) and treatment with hydrogen peroxide (SpH2O2). Arrows point to the emerging
spheroids. Scale bars, 50 μM. n; po0.05, nn; po0.005, nnn; po0.0005.
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high selectivity for H2S over oxygen and nitrogen and other
reactive sulfur species such as cysteine and glutathione [35].
Using this probe, the parental control cells are dim while the DR
cells exhibit an intense ﬂuorescence (Fig. 1F).
We also observed that a population of DRH2O2 cells forms 3D
spheroid (SpH2O2) structures which are surrounded by a mono-
layer of cells. In contradistinction, the parental cells fail to form
similar structures under identical culture conditions in standard
culture media supplemented with 10% FBS (Fig. 1G). Similar DR
cells forming spheroids appeared following recovery from
damage induced by hypoxia (O2 level below 1%) for 18 h (SpH)
or glucose deprivation for 18 h (SpG). The compact multi-cellular
spheroid colonies were consistently formed independent of the
type of damage that cells endured or the type of cells that were
damaged (HepG2, MDA-MB-231, MDA-MB-435S, and CT26)
(Fig. 1G, Supplementary Fig. 2E). The highest increase in H2S
production was observed in 3D spheroids as compared to other
cancer cells in the same dish that grew as a monolayer and failed
to form spheroids (Fig. 1E–F). The increased cell–cell interaction in3D cultures was associated with modiﬁcation of gene expression
and alteration of cell–cell adhesion as evidenced by expression of
E-cadherin. To study these spheroids in more details, spheroids
were cultured in a mediumwhich was supplemented with 5% FBS
on low adhesion plates to promote self-renewal.Spheroids formed following recovery from potentially
lethal damage show enhanced H2S-producing activity
The relative level of mRNA for CBS and CTH increased in DRH2O2 cells
with highest increase in SpH2O2 colonies (Fig. 2A–B). There was
also a signiﬁcant difference in the level of MST mRNA in Pc, DRH2O2
and SpH2O2 cell populations (Fig. 2A). The MST mRNA was unde-
tectable in both Pc and DRH2O2 cells whereas its expression was
readily detected in DR derived SpH2O2 cells. The endogenous CTH
and CBS protein levels increased over 2 folds in spheroid colonies
(Fig. 2C–D). It is known that infusion of H2S may change the NADþ
level [36]. We found that after recovery from damage, NADþ was
signiﬁcantly increased in cancer cells forming Sp colonies (Fig. 2E).
Fig. 2 – Recovery from potentially lethal damage requires activation of Nampt. A. CBS, CTH and MST gene expression levels were
evaluated by RT-PCR analysis in DRH2O2 and DR derived spheroid cells (SpH2O2) generated under oxidative stress induced by H2O2. B.
CBS mRNA expression in SpH2O2 cells relative to Pc cells. The expression level was measured by real time PCR analysis and
normalized with the expression of β-actin. C. Western blot analysis of CTH and CBS protein expression in DRH2O2 cells and DR
derived SpH2O2 cells. β-actin was used as a loading control. D. Relative level of CTH and CBS proteins normalized to β-actin. E. Left
panel: The contents of NADþ and Nampt were measured in HepG2 Pc and SpH cells. Right panel: The content of NADþwas measured
in HepG2 Pc and SpH2O2 cells. NADþ and Nampt levels were normalized to the level of total protein. F. Western blot analysis of
Nampt in DR cells and spheroids (Sp) generated under glucose deprivation (G), hypoxia (H) and oxidative stress induced by H2O2
(H2O2). G. Relative level of Nampt protein normalized to β-actin. Levels of NADþ(H) and Nampt (I) in HepG2 Pc cells treated with
100 μM of NaHS for 48 h. Nampt protein level was determined by ELISA based assay. n; po0.05,nn; po0.005, nnn; po0.0005.
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cided with increase in Nampt, which is required for synthesis of
NADþ and repair (Fig. 2F–G). The observed increase in Nampt was
independent of type of damage. To further assess the importance of
H2S in upregulation of Nampt, Pc cells were treated with H2S donor,
NaHS. Similar to our observations in DRH2O2 and SpH2O2 cells,
treatment of Pc cells with NaHS increased level of Nampt and
coordinately increased NADþ output (Fig. 2H–I). Accumulation of
H2S and increased synthesis of NADþ resulted in increased tolerance
of DR cells towards damage and nutrient depletion. Compared to Pccells, cells recovered from damage showed increased resistance
to such cancer drugs as cisplatin or bleomycin (Supplementary
Fig. 3A–C) to nutrient deprivation (Supplementary Fig. 3D).
Endogenous hydrogen sulﬁde generated by cancer cells
recovered from damage directs cells into acquisition of a
dedifferentiated state
The observed altered cancer cell phenotype as manifested by the
formation of 3D spheroids suggested that these DR cells undergo
E X P E R I M E N T A L C E L L R E S E A R C H 3 3 0 ( 2 0 1 5 ) 1 3 5 – 1 5 0 141dedifferentiation. To determine whether cells forming spheroidal
colonies contain undifferentiated cells, we studied the expression
of several genes characteristic of stem cells. To examine expres-
sion proﬁle of OCT4, we designed primers that avoided ampliﬁca-
tion of OCT4 pseudogenes. Furthermore, we used primers that
distinguish between OCT4A isoform, which is highly expressed in
ESC, and OCT4B variant, which is up-regulated only in response to
damage [37–38]. Compared to the Pc cells, the DR derived Sp cells
had an elevated level of expression of OCT4A, NANOG, KLF4
(Kruppel-Like Factor 4), SSEA1 (Stage-Speciﬁc Embryonic Antigen),
DPPA2 (Developmental Pluripotency Associated 2 gene), and
FBXO15, while expression of damage inducible OCT4B was negli-
gible (Fig. 3A, Supplementary Fig. 4A–D). Only DR and Sp cells
expressed stem cell markers such as OCT4 and NANOG (Fig. 3B and
Supplementary Fig. 4C–D). The level of expression of OCT4 and
Oct4 protein were also up-regulated in DR cells as compared to
that detectable in Pc cells (Fig. 3B–C). Increase in OCT4 expressionFig. 3 – Damage Recovered (DR) cells forming 3D spheroids exhibi
SSEA1, DPPA2, FBXO15 and HIF1α gene expression levels in HepG2 P
ACTIN gene expression level served as a loading control. B. RT-PCR
GAPDH gene expression level served as a loading control. C. Oct4 p
parental Pc and DRH GFP labeled CT26 cells viewed under phase c
ﬂuorescent microscope (right panel). Red staining indicates Oct4 pr
DRH cells were Oct4-positive. Scale bars, 100 μM. D. Immunostainin
Alkaline phosphatase staining of HepG2 Pc, SpH2O2 and SpH cells. Sc
β‐ACTIN in Pc HepG2 cells treated with 0 and 100 μM of NaHS for 48
NaHS for 24 h. n; po0.05,nn; po0.005, nnn; po0.0005.associated with staining for Oct4 protein (shown in red) in CT26
DRH cells clearly indicates that the expression of OCT4 is not due
to expression of stress induced OCT4B variant or OCT4 pseudo-
genes (Fig. 3C). CT26 DRH cells were positively stained for
glycolipid antigens SSEA1 and SSEA4, surface markers for undif-
ferentiated stem cells (Fig. 3D). The dedifferentiation of Sp cells
was further conﬁrmed by alkaline phosphatase staining, which is
a sensitive indicator of an undifferentiated state (Fig. 3E) [39]. The
expression of stem cell markers was associated with accumula-
tion of H2S and increased NADþ and Nampt. In order to validate
the functional role of H2S in dedifferentiation, we explored the
efﬁciency of NaHS in inducing expression of stem cell markers.
The treatment of Pc cells with NaHS led to expression of OCT4 and
NANOG, while HIF1α expression was down-regulated (Fig. 3F).
NaHS also increased the level of E-CADHERIN (Fig. 3F), which was
shown to be essential for the maintenance of cell integrity and an
undifferentiated state [40].t an undifferentiated phenotype. A. OCT4 (A/B), NANOG, KLF4,
c, SpH2O2, SpH and SpG cells were assessed by RT-PCR analysis. β‐
analysis of OCT4 gene expression in CT26 Pc and DRH cells.
rotein expression in CT26 DRH cells. Monolayer culture of CT26
ontrast (left panel) and GFP and Oct4 protein labeled under
otein. Immunoﬂuorescence staining revealed that a majority of
g of SSEA1 and SSEA4 in CT26 parental Pc and DRH cells. E.
ale bars, 100 μM. F. RT-PCR analysis of HIF1α, NANOG, OCT4, and
h and E-CADHERIN in HepG2 Pc cells treated with 0 and 10 μM
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manner
As expected, the treatment of DR cells with DL-propargylglycine
(PAG) that inhibits CBS and CTH reduced H2S accumulation
(Fig. 4A). Most strikingly, although, there was no cytotoxicity in
cancer cells treated with FK866 observed after 24 h (data not
shown), treatment of HepG2 cells with FK866 inhibited Nampt,
and decreased the production of H2S (Fig. 4A). Consistent with
change in H2S production, the levels of CBS and CTH protein
expression were diminished by treatment with FK866 (Fig. 4B).
The treatment of HepG2 SpH2O2 cells with FK866 led to down-
regulation of CBS gene expression and coordinately caused a 2
fold decrease in H2S production (Fig. 4C–D). Inhibition of
H2S by PAG abated the expression of OCT4, NANOG and
E-CADHERIN in Sp cells, showing that expression of stem cell
markers in Sp cells is H2S driven (Fig. 4E–G). Similar levels of
suppression of stem cell markers was achieved by treatment of Sp
cells with FK866 (Fig. 4E–F). Suppression of NAMPT by FK866Fig. 4 – H2S and Nampt promote an undifferentiated phenotype. A.
CTH inhibitor, PAG (100 μM, 18 h), and Nampt inhibitor, FK866 (20
DRH2O2 HepG2 whole cell lysate (WCL) in the absence and presence
DRH2O2 cells treated with FK866 and immunoblotting (IB) analysis
of H2S released from SpH2O2 HepG2 cells treated with Nampt inhibi
real time PCR in SpH2O2 HepG2 cells treated with Nampt inhibitor,
NAMPT gene expression in SpH2O2 and SpH HepG2 cells treated wit
PCR analysis shows changes in the expression of OCT4, NANOG an
(100 μM, 18 h), and Nampt inhibitor, FK866 (200 nM, 24 h). Express
n; po0.05,nn; po0.005, nnn; po0.0005.decreased expression of stem markers, KLF4, NANOG, SOX2, and
FBOX15 (Fig. 5 A–B). To further validate the role of Nampt on
dedifferentiation, we carried out a NAMPT knockdown experi-
ment using NAMPT siRNA. Spheroid HepG2 colonies were dis-
sociated by trypsinization into a single cell suspension for
successful transfection. NAMPT expression was diminished only
in cells that were transfected with the siRNA to NAMPT and not by
non-target speciﬁc scrambeled siRNA (Fig. 5A and B). However, no
change in the expression of OCT4A/B, DPPA2 and SSEA1 was found
in cells that were transfected with NAMPT siRNA. NAMPT-knock-
down by Nampt siRNA diminished the expression of CBS leading
to reduced intracellular production of H2S (Fig. 5A and C).
However, expression of CTH was not affected by Nampt siRNA
(Fig. 5C). Furthermore, we observed that NAMPT-knockdown
prevented the formation of spheroidal colonies. Interestingly,
NAMPT depleted cells exhibited single cells and led visibly to
formation of small ‘stressed’ spheres, whereas in cells that were
treated with control siRNA, spheroids were formed 3 days after
transfection (Fig. 5D).Amount of H2S released from DRH2O2 HepG2 cells treated with
0 nM, 24 h). B. Immunoblotting (IB) analysis of CTH and CBS in
of FK866 (200 nM, 24 h). Immunoprecipitation (IP) of CTH from
of the immunoprecipitates with anti-CTH antibody. C. Amount
tor, FK866 (200 nM, 24 h). D. Expression level of CBS assessed by
FK866 (200 nM, 24 h). E. RT-PCR analysis of OCT4, CTH and
h either PAG (100 μM, 18hr) or FK866 (200 nM, 24 h). Real time
d E-CADHERIN in SpH2O2 (F) and SpH (G) cells treated with PAG
ion levels were normalized with the expression of β‐ACTIN.
Fig. 5 – Depletion of Nampt by small interfering RNA (siRNA) reduces dedifferentiation capacity of cells recovered from damage.
Cells were transfected with NAMPT siRNA or scrambled control siRNA. Gene expression (A and B), H2S production (C) and Sp colony
formation (D) were analyzed 72 h later. A. OCT4 (A/B), NANOG, KLF4, SSEA1, DPPA2, FBXO15, CBS and CTH gene expression levels in
HepG2 SpH2O2 cells were assessed by RT-PCR analysis. β‐ACTIN gene expression level served as a loading control. B. Real time PCR
analysis shows changes in the gene expression in SpH2O2 cells transfected with NAMPT siRNA. C. Amount of H2S released by SpH2O2
cells transfected with NAMPT siRNA or scrambled control siRNA. D. Representative phase contrast images of spheroids formed
from single SpH2O2 cells transfection with NAMPT siRNA or scrambled control siRNA.
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cancer cells in in vivo generated tumors
To identify whether cells similar to in vitro generated Sp cells exist
or can be generated in tumors, epithelial cancer cells of different
lineages were inoculated into immunodeﬁcient mice. Tumors that
grew subcutaneously were removed, and were subjected to
collagenase treatment.
The isolation of viable tumor (TV) cells and damaged (TDR)
tumor cells was followed as described in our previous study [32].
Within 1 week, similar to in vitro generated DR cells, TDR cells
formed 3D spheroid (TSp) structures along with a monolayer of
cells (Fig. 6A, Supplementary Fig. 5A). TSp colonies, generated in
the midst of TDR cells, were comprised of cells that formed
cohesive colonies with distinct colony borders. As compared with
viable cells isolated from tumors (TV), TSp cells produced the
highest amounts of H2S (Fig. 6B–C, Supplementary Fig. 5B–C).
Given the importance of redox homeostasis in the regulation of
stem cells, we found that TSp cells showed diminished NADþ/NADH
ratio and a greatly elevated intracellular thiol levels consistent with
accumulation of H2S and a more reduced redox state (Fig. 6D–E).
Importantly, although NADþ/NADH ratio decreased, the total levels
of NADþ and NADH were increased (Fig. 6E). NAMPT gene and
protein expression were also signiﬁcantly increased in TSp cells
(Fig. 6F–G).
The TSp cells expressed stem cell markers including OCT4,
NANOG, E-CADHERIN, SOX2 and AFP (Fig. 7A–B, SupplementaryFig. 6A–B). These cells were alkaline phosphatase positive, a
phenotypic marker of stem cells (Fig. 7C). The TSp cells expressed
E-CADHERIN, while the level of SNAIL, which induces a switch
from E-CADHERIN to N-CADHERIN was diminished (Fig. 7B,
Supplementary Fig. 6B). Treatment of TSp cells isolated from
HepG2 tumors formed in nude mice led to a signiﬁcantly
diminished expression of E-CADHERIN (Fig. 7D).
Adipogenic potential of Sp colonies formed by cancer cells
recovering from damage
We questioned whether cancer cells which acquire a dedifferen-
tiated phenotype could be forced to differentiate again. The spher-
oidal DR (SpH2O2) cancer cells, which expressed the stem cell
markers, showed a high degree of plasticity and could differentiate
along the adipogenic pathway (Fig. 8A–C). Expression of the
adipocyte marker, ADIPONECTIN, was higher in SpH2O2 cells rather
than Pc cells that were treated with 1% DMSO and this expression
coincided with the disappearance of OCT4A (Fig. 8A–B, Suppl-
ementary Fig. 7A). There was no ADIPONECTIN mRNA expression
in either Pc or DR cells, which did not show the potential to
transition into an undifferentiated state. Despite the expression of
ADIPONECTIN, SpH2O2 cells also retained cytokeratin 18, a phenotypic
marker of epithelial cells (Fig. 8A). To conﬁrm adipogenic differ-
entiation, cells were stained with triglyceride dye, Oil-Red-O. Bright
ﬁeld microscopy of Sp cells growing on gelatin and treated with
DMSO revealed these cells to be ﬁlled with lipid droplets that
Fig. 6 – Spheroid formation in cells isolated from HepG2 xenograft tumor coincides with elevated levels of H2S and Nampt. A.
Representative phase contrast images of emerging spheroids from cells isolated from in vivo generated HepG2 tumors. Scale bars,
100 μM. B. HepG2 (lower panel) Pc and TSp cells staining with H2S ﬂuorescent probe, HSN2. Scale bars, 50 μM. C. H2S in Tv and TSp
cells isolated from in vivo generated HepG2 tumors. D. Total thiol levels in Tv and TSp cells isolated from in vivo generated HepG2
tumors. The levels were normalized to the level of total protein. E. Levels of NADþ and NADþ/NADH ratio in TV and TSp cells isolated
from in vivo generated HepG2 tumors. The levels of NADþ and NADH were normalized to the level of total protein. F. Expression
level of NAMPT mRNA assessed by real time PCR in TV, and TSp cells isolated from in vivo generated HepG2 tumors. G. Nampt
protein level assessed by ELISA in TV, TDR and TSp cells isolated from in vivo generated HepG2 tumors compared with that in Pc
HepG2 cells. n; po0.05,nn; po0.005, nnn; po0.0005.
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with DMSO failed to show any Oil-Red-O positive cells. The
differentiation of SpH2O2 cells along the adipogenic pathway was
associated with a decrease in H2S production and expression of
NAMPT (Fig. 8D–E). Under the same differentiation condition, in
contrast to SpH2O2 cells, SpH cells did not exhibit adipogenic
differentiation as evident by the lack of positive Oil-Red-O staining
and the absence of ADIPONECTIN gene expression (data not shown).
However under the same conditions, SpH cells strongly expressed
MYOGENIN mRNA while they lost the expression of OCT4A
(Supplementary Fig. 7A–B). Similar to SpH2O2 cells, upon this
differentiation, expression of NAMPT was severely diminished in
SpH cells (Supplementary Fig. 7A). Overall, it is plausible to suggest
that diminished H2S production and downregulation of Nampt
result in a more oxidizing cellular environment which is a pre-
requisite for differentiation. However, tissue-speciﬁc differentiation
programs are not predetermined by these changes. TSp cells isolated
from MDA-MB-231 xenograft tumors did not show adipogenic
potential (Supplementary Fig. 7C–D). However, similar to HepG2
SpH2O2 cells, TSp cells isolated from HepG2 xenograft tumors could
be forced to differentiate along the adipogenic line as evidenced by
30 fold increase in ADIPONECTIN gene expression in DMSO treated
TSp cells grown on gelatin (Fig. 8F). The increase in ADIPONECTINgene expression was associated with a signiﬁcant increase in the
number and intensity of Oil-Red-O staining in DMSO treated TSp
cells grown on gelatin (Fig. 8G). In contrast to these cells, Tv cancer
cells that did not show the ability to form spheroids nor expressed
stem cell markers failed to show adipogenic potential when treated
with DMSO (Fig. 8G). Instead, these TSp cells expressed high levels of
FIBRONECTIN, which is considered a marker of mesenchymal
differentiation and a hallmark of epithelial to mesenchymal transi-
tion (Supplementary Fig. 7D). Similar to MDA-MB-231TSp, MDA-MB-
435 TSp cells did not exhibit adipogenic potential (Supplementary
Fig. 7C).
Together, our ﬁndings show the potential of cancer cells to recover
from damage and that such recovery leads to generation of undiffer-
entiated cells with the capability of transdifferentiation.Discussion
The plasticity of cancer cells and their differentiation has been
attributed to changes in the tumor microenvironment [14–16].
Among the putative factors in the microenvironment that modulate
plasticity are inter-cellular networks, changes in extracellular matrix,
ﬂuctuation in oxygen tension, chronic inﬂammation triggered by an
Fig. 7 – Spheroid cells isolated from in vivo HepG2 xenograft tumor (TSp) show expression of stem cell associated genes. A.
Expression level of OCT4, NANOG, E-CADHERIN, SOX2, and α-FETOPROTEIN (AFP) assessed by real time PCR. β‐ACTIN expression was
used for normalization. B. RT-PCR analysis of OCT4, NANOG, SOX2, E-CADHERIN, SNAIL and β‐ACTIN. C. Representative images of
alkaline phosphatase staining in Tv cells (upper image) and TSp cells. Scale bars, 250 μM. D. Expression level of NANOG and E-
CADHERIN assessed by real time PCR in TSp cells treated with PAG (100 μM, 18 h) or FK866 (200 nM, 24 h). n; po0.05,nn; po0.005,
nnn; po0.0005.
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have emphasized that low oxygen tension promotes and maintains
the undifferentiated state of the stem cells [42–43]. In that sense, it is
conceivable that response to damage exerted by hypoxia, acidosis or
oxidative stress, which all occur in the tumor microenvironment, all
favor cancer cell adaptation via increasing cell plasticity. This idea
appears to be also applicable to normal cells as evidenced by a recent
report showing that airway epithelial cells undergo dedifferentiation
and convert into functional stem cells in response to the genotoxic
drug, doxycycline [20]. Furthermore, the expression of OCT4 and
NANOG was shown in adipose tissue-derived stromal cells, which
were maintained under hypoxic conditions (2% O2) for over a span of
6 weeks [44].
The generation of spheres/mammospheres from single cells
under non-adherent conditions in selective media is a widely used
approach for enrichment of stem-like cells from cell lines and
primary tumors. The spheroidal colonies were mostly generated on
low adhesion plates by cells that were maintained in a serum free
medium containing EGF and/or bFGF at 10–20 ng/ml supplemented
with insulin, hydrocortisone and B27, which serves as a serum
replacement. Using this approach, spheroidal colonies were gen-
erated from various primary cancers and cell lines such as T47D-
C42, MCF7, MDA-MB231, MDA-MB468, BT474, and others [45–46].
However, no more than 3% of cells in spheroids were positive foraldehyde dehydrogenase-1 (ALDH), which was used to identify
CSC. It should be pointed out that ALDH is also indicator of damage
since it serves to mitigate cellular oxidative stress. While most cells
from breast duct cells die under such conditions, a small number of
cells survive which generate ﬂoating spheroidal colonies [47].
Similarly, spheroids isolated from primary ovarian cancer speci-
mens show increased ALDH activity [48]. Data provided here
suggest that spheroid cells with stem cell-like properties are
generated in tumor cells that recover from any damage such as
that induced by hypoxia, glucose deprivation, or acidosis, which all
occur in the tumor microenvironment. Recently, Pease J.C and
colleagues demonstrated spheroid formation in dense regions of
cultures from four ovarian cancer cell lines [49]. Spheroid budding
from monolayer correlated with epithelial to mesenchymal transi-
tion and led to drug resistance. However, dissociation of spheroids
into a monolayer fully restored their drug sensitivity. Here, we
show that cells that recover from damage, have elevated levels of
H2S and maintain a long term tolerance not only to depletion of
nutrients but also show resistance to damage induced by drugs
that are used in the treatment of cancer including bleomycin and
cisplatin. It was shown that drug resistance is directly proportional
to tumor size [50]. Consistent with this, our recently reported
ﬁndings demonstrated that DR cells inoculated to immunodeﬁcient
mice formed larger tumors than those produced by Pc cells within
Fig. 8 – Spheroid cells from HepG2 tumor cells recovering from potentially lethal damage and cancer cells isolated from in vivo
generated HepG2 tumors show adipogenic plasticity. Sp cells were cultured on 2% gelatin as ECM in the absence () and presence
(þ) of 1% DMSO for 5 days. A. The expression of ADIPONECTIN and CYTOKERATIN 18 was assessed by RT-PCR analysis in Pc, DRH2O2
and SpH2O2 cells. B. Relative level of ADIPONECTIN gene expression normalized to β‐ACTIN in Pc and SpH2O2 cells. C. Oil-Red-O
staining of Pc and SpH2O2 cells. Arrows point to Oil-Red-O positive cells. Scale bars, 50 μM. D. The expression of NAMPT in SpH2O2
cells was assessed by RT-PCR analysis. E. H2S production in 3D SpH2O2 cells cultured on with (þ) or without () 2% gelatin. F.
Expression level of ADIPONECTIN assessed by real time PCR in 3D TSp cells and TSp. G. Oil-Red-O staining of HepG2 Tv and TSp cells
isolated from in vivo generated tumors. Scale bars, 50 μM. nn; po0.005, nnn; po0.0005.
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show increased drug resistance associated with expression of stem
cell markers are more tumorigenic as compared to their parental
counterpart cells. Cell dedifferentiation contributes to proliferation
rate. Thus, SOX2 overexpression alone is sufﬁcient to drive cell
proliferation by facilitating G1/S transition, whereas conditional
deletion of SOX2 was shown to decrease tumor formation after
chemical-induced carcinogenesis [51–52].
Following recovery from damage, cancer cells of different lineages
are stimulated to dedifferentiate. The results suggest that cancer cell
phenotype is dynamic and stemness may be acquired through ded-
ifferentiation following recovery from damage. The ability of cancer
cells to acquire stem-speciﬁc gene expression and to transdifferentiatewas proportional to the amount of H2S and Nampt mediated increase
in NADþ. Consistent with this, inhibition of H2S producing enzymes,
their inhibitor, PAG, [53] signiﬁcantly diminished the ability of cells to
undergo dedifferentiation. In part, hydrogen sulﬁde exerts its effects
by reducing the intracellular redox environment that favors the
transition into an undifferentiated state. This is not surprising since
H2S was shown to ameliorate hypoxic and oxidative stress induced
injury due to its ability to scavenge oxidative species and to increase
the pool of reduced glutathione [54–58]. Tumor cells that survive
acidic conditions demonstrate increased tolerance to damage and
become dependent on low pH for prolonged survival [59]. H2S is a
weak acid and readily ionizes in aqueous solutions. At physiological
pH, approximately 70% of total H2S exists in anionic form as HS ,
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[60]. The increase in amount of H2S has an impact on total level of
thiols and is associated with an increased cytoprotection. Thus,
cytoprotective effectiveness of H2S and its ability to promote the
dedifferentiation might be dependent on microenvironmental condi-
tions. Consistent with our observations, stem cells reside in niches
which are characterized by a reduced redox state, critical for main-
taining stemness, whereas oxidizing redox state promotes their
differentiation [61–62]. Furthermore, the effect of H2S on expression
of stem cell markers is attributable to its ability to upregulate Nampt
and, therefore, to the increase intracellular availability of NADþ. This
idea is supported by the ﬁnding that suppression of Nampt by its
speciﬁc inhibitor, FK866, abrogates the expression of genes associated
with an undifferentiated state. Nampt protein is overexpressed in
multiple cancers and its inhibition suppresses the tumor growth. It
was shown that inhibitors of Nampt prevent tumor spheroid forma-
tion, which is indicative of ability of single primary tumor cells to
expand and repopulate tumors [63]. Nampt exerts its effects via
regulation of level of NADþ. Similar to our results, it was shown that
upon depletion of NADþ, human induced pluripotent cells lose their
ability to remain undifferentiated [64]. The relative concentration of
NADþ and NADH can be interconversed via oxidation/reduction
reactions. However, only NADH can be signiﬁcantly altered. Since
oxygen is the ﬁnal acceptor of reducing equivalent transferred by
NADH, low oxygen tension results in an elevated NADH content.
Increase in reduced NADH also indicates a shift in the intracellular
redox state towards a more reducing environment.
Our results indicate that cancer cells that recover from damage
induced by hypoxia or oxidative stress, and which express stem cell
markers, also harbor the potential to transdifferentiate into new
lineages underscoring development of new potencies. Although
DMSO generally has an inhibitory effect on adipocyte differentia-
tion in 3T3 L1 ﬁbroblasts and 3T3 T mesenchymal stem cells [65],
we have found that it promotes adipogenic differentiation of some
damage recovered cancer cells. Adipogenic transdifferentiation
may contribute to metabolic changes and affect tumor microenvir-
onment. Upon adipogenic differentiation, mesenchymal stem cells
were shown to acquire higher oxygen consumption and higher
rates of reactive oxygen production which is indicative of a shift in
redox environment to a more oxidized state [66]. Despite the high
levels of mitochondrial respiration, differentiating mesenchymal
stem cells were characterized by low ATP production and mito-
chondrial membrane potential. It is possible that at early stages of
adipogenesis, a decrease in NAMPT expression might be the cause
of a bioenergetic shortage. We show that transformation of tumor
spheroid cells into cells showing an adipocytic phenotype was
associated with a decrease in the expression of NAMPT and low
production of H2S. Consistent with our data, the knockdown of
NAMPT or its direct inhibition by FK866 was shown to increase
adipocyte formation in the mouse mesenchymal cell line C3H10T1/
2 and in primary bone marrow stromal cells [67]. Furthermore,
hypoxia was reported to inhibit adipogenic differentiation [66].
This evidence may explain the underlying cause for the inability of
the spheroid cells recovered from hypoxia to transdifferentiate
towards the adipogenic lineage. Li et. al. showed that during
osteogenic differentiation of the multipotent mouse ﬁbroblast,
C3H10T1/2, and the omnipotent preosteoblast MC3T3-E1 cells,
increase in NAMPT expression is followed by a rise in intracellular
NADþ [68]. However, the authors show that early, during differ-
entiation stage (on day 3), the expression level of NAMPT was notchanged in MC3T3-E1 cells. We speculate that the observed
difference in transdifferentiation potential between Sp cells gener-
ated from damage recovered HepG2 (ERþ) cells and MDA-MB-231
and MDA-MB-435 (ER-) cells might be attributable to the status of
estrogen receptor in these cells. Estrogen-related receptor-α (ERRα)
has been reported to have a positive regulatory role in adipocytic
differentiation, whereas cells deﬁcient in ERRalpha were shown to
display osteoblastic differentiation and mineralization [69–70]. It
was reported that the plasticity shown towards osteogenesis and
adipogenesis of human mesenchymal stem cells extend into
osteogenic differentiation pathway with few cells still displaying
adipogenic markers [71]. Moreover, it was recently shown that in
bone marrow mesenchymal stem cells, H2S regulates both self-
renewal and osteogenic differentiation [72]. These ﬁndings suggest
that the effect of H2S on transdifferentiation might be contextual
and might differ in cells of different lineages.
Taken together, data presented here suggest that H2S–Nampt circuit
plays an important role in cell fate determination. Upregulation of
ADPONECTIN gene expression shows the ability of damage recovered
cancer cells that form spheroids to transdifferentiate. Such a trans-
differentiation potential is signiﬁcant since it has been shown that
adiponectin increases cell survival in glucose deprived colorectal
cancer cells through enhancement of an autophagic response and
induction of tumor vascularization in mammary cancers [73–74]. Full
understanding of potential of cancer cells to dedifferentiate upon
recovery from damage and the potency to transdifferentiate and to
transform to new phenotypes has diverse implications in tumor cell
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